Eskola O - Search Results

1

Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer.

Lehtiö K, Eskola O, Viljanen T, Oikonen V, Grönroos T, Sillanmäki L, Grénman R, Minn H. Lehtiö K, et al. Among authors: eskola o. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):971-82. doi: 10.1016/j.ijrobp.2003.12.014. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234030

2

Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18-fluoro-6-thia-heptadecanoic acid.

Mäki MT, Haaparanta M, Nuutila P, Oikonen V, Luotolahti M, Eskola O, Knuuti JM. Mäki MT, et al. Among authors: eskola o. J Nucl Med. 1998 Aug;39(8):1320-7. J Nucl Med. 1998. PMID: 9708500 Free article.

3

Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.

Ruottinen HM, Niinivirta M, Bergman J, Oikonen V, Solin O, Eskola O, Eronen E, Sonninen P, Rinne UK. Ruottinen HM, et al. Among authors: eskola o. Synapse. 2001 Apr;40(1):19-26. doi: 10.1002/1098-2396(200104)40:1<19::AID-SYN1022>3.0.CO;2-7. Synapse. 2001. PMID: 11170218

4

Pharmacokinetics of [18F]FETNIM: a potential marker for PET.

Grönroos T, Eskola O, Lehtiö K, Minn H, Marjamäki P, Bergman J, Haaparanta M, Forsback S, Solin O. Grönroos T, et al. Among authors: eskola o. J Nucl Med. 2001 Sep;42(9):1397-404. J Nucl Med. 2001. PMID: 11535732 Free article.

5

Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET.

Lehtiö K, Oikonen V, Grönroos T, Eskola O, Kalliokoski K, Bergman J, Solin O, Grénman R, Nuutila P, Minn H. Lehtiö K, et al. Among authors: eskola o. J Nucl Med. 2001 Nov;42(11):1643-52. J Nucl Med. 2001. PMID: 11696633 Free article.

6

S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.

Marjamäki P, Zessin J, Eskola O, Grönroos T, Haaparanta M, Bergman J, Lehikoinen P, Forsback S, Brust P, Steinbach J, Solin O. Marjamäki P, et al. Among authors: eskola o. Synapse. 2003 Jan;47(1):45-53. doi: 10.1002/syn.10150. Synapse. 2003. PMID: 12422372

7

18F-Fluoroerythronitroimidazole radiation dosimetry in cancer studies.

Tolvanen T, Lehtiö K, Kulmala J, Oikonen V, Eskola O, Bergman J, Minn H. Tolvanen T, et al. Among authors: eskola o. J Nucl Med. 2002 Dec;43(12):1674-80. J Nucl Med. 2002. PMID: 12468519 Free article.

8

Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio.

Lehtiö K, Oikonen V, Nyman S, Grönroos T, Roivainen A, Eskola O, Minn H. Lehtiö K, et al. Among authors: eskola o. Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):101-8. doi: 10.1007/s00259-002-1016-x. Epub 2002 Oct 30. Eur J Nucl Med Mol Imaging. 2003. PMID: 12483416 Clinical Trial.

9

Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.

Forsback S, Niemi R, Marjamäki P, Eskola O, Bergman J, Grönroos T, Haaparanta M, Haapalinna A, Rinne J, Solin O. Forsback S, et al. Among authors: eskola o. Synapse. 2004 Feb;51(2):119-27. doi: 10.1002/syn.10293. Synapse. 2004. PMID: 14618679

10

Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.

Grönroos T, Bentzen L, Marjamäki P, Murata R, Horsman MR, Keiding S, Eskola O, Haaparanta M, Minn H, Solin O. Grönroos T, et al. Among authors: eskola o. Eur J Nucl Med Mol Imaging. 2004 Apr;31(4):513-20. doi: 10.1007/s00259-003-1404-x. Epub 2004 Jan 14. Eur J Nucl Med Mol Imaging. 2004. PMID: 14722675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters